CoChat

Hormone replacement therapy in women with past history of endometriosis

Soliman, N. F., Hillard, T. C. · 2006 · Climacteric

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.

Abstract

Endometriosis is a common clinical condition and its treatment will often lead to an estrogen deficiency status. As most of these patients are young, they will need to consider hormone replacement therapy. Endometriosis is a hormone-dependent disease and estrogen replacement can be associated with a risk of recurrence or malignant transformation. Only a few studies have addressed this problem. With the use of hormone replacement therapy (HRT), there is an increased, although undefined, risk of recurrence of endometriosis, especially in known severe cases and in obese patients. Unopposed estrogen appears to carry a higher risk than combined preparations. Delay in starting HRT after pelvic clearance is not of any benefit. After radical surgery for severe endometriosis, women often have much to gain from HRT, particularly in the early years. Benefits of HRT in terms of control of menopausal symptoms, prevention of urogenital atrophy and loss of libido and bone protection are of particular importance. HRT may still have a role in prevention of cardiovascular disease in early menopause, but this remains unproven. Although there is no firm evidence, continuous combined preparations or tibolone would appear to be the optimum choice.

Overview

Integrity signals

Registry

Crossref · 10.1080/13697130600868711

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 72 references

Research works printed but not linked: 12

  1. Kempers R D, 1960, Surg Gynaecol Oncol, 111, 348
  2. Schor E, 1999, Clin Exp Obstet Gynaecol, 26, 158
  3. Berguld A S, 2003, Hum Reprod, 18, 80
  4. Lauslahti K, 1972, Acta Pathol Microbiol Scand A, 80, 98
  5. Heaps J M, 1990, Obstet Gynecol, 75, 1023
  6. Granai C O, 1984, Obstet Gynecol, 64, 592
  7. Berkowitz R S, 1978, Obstet Gynecol, 51, 34
  8. Remnitz C, 1988, Obstet Gynecol, 1, 444
  9. Abu M AE, 1997, Eur J Gynecol Oncol, 18, 482
  10. Larvey S, 2001, Br J Obstet Gynaecol, 108, 1106
  11. Areia A, 2004, Eur J Gynaecol Oncol, 25, 225
  12. Beral V, 2005, Lancet, 30, 1543

Cited by

See all 65

Metadata

Authors
Soliman, N. F., & Hillard, T. C.
Affiliations
  • Yeovil District Hospital (GB)
  • Poole Hospital (GB)
Corresponding author
Hillard, T. C.
Venue
Climacteric
Published
2006-01
Volume
9
Issue
5
Pages
325-335
ISSN
  • 1369-7137 (ISSN-L)
  • 1473-0804
OpenAlex
W2109120076
Cited by
65
References
70
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 5 · 2018: 2 · 2017: 5 · 2016: 4 · 2015: 2 · 2014: 3 · 2013: 4 · 2012: 4
FWCI
0.52
Type
journal article
Language
en
Open access
closed
Locations
  • Climacteric (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
Keywords
hormone replacement therapy, endometriosis, estrogen deficiency, endometriosis recurrence, malignant transformation, unopposed estrogen, combined estrogen-progestogen therapy, tibolone, menopausal symptoms, urogenital atrophy, bone protection, cardiovascular disease prevention, early menopause, obesity
MeSH terms
Adult, Aged, Endometriosis, Female, Humans, Hysterectomy, Menopause, Middle Aged, Norpregnenes, Risk Factors, Estrogen Replacement Therapy, Endometrial Neoplasms, Estrogen Receptor Modulators

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hormone replacement therapy in women with past history of endometriosis. https://app.cochat.ai/papers/10.1080/13697130600868711
The paper
Soliman, N. F., & Hillard, T. C. (2006). Hormone replacement therapy in women with past history of endometriosis. Climacteric. https://doi.org/10.1080/13697130600868711

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.